Objectives-To determine the effect of intravenous regional guanethidine on post-traumatic algodystrophy. Methods-Ten of 20 consecutive patients with algodystrophy after Colles' fracture were treated with serial intravenous regional guanethidine blockades and the other 10 were treated with physiotherapy alone. Patients were assessed before and after each block and then monthly over a six month period. Results-The treated patients had subjective and objective improvements in the assessed features of algodystrophy; treatment resulted in a significant reduction in finger tenderness at five and six months. Conclusions-Guanethidine blockade induces short term benefits in the symptoms of algodystrophy but improves finger tenderness only in the long term.
Algodystrophy (reflex sympathetic dystrophy or Siudeck's atrophy) is a syndrome affecting the hands and feet and occurring most often after trauma. ' In the hands the disorder consists of excessive tenderness of the fingers, joint stiffness, swelling, and vasomotor instability (temperature and sudomotor control). As the disorder progresses regional osteoporosis and atrophy of the subcutaneous tissues occur, leading to debilitating soft tissue contractures.
Hannington-Kiff first reported the technique of intravenous regional guanethidine for the treatment of algodystrophy2 and since then its use has been widely accepted, though Casale et al3 have noted the effectiveness of the tourniquet only. Studies have mainly relied on subjective evidence of improvement using this treatment,4 5 but objective evidence of short term improvement after guanethidine treatment has been reported.6
It is the purpose of this paper to assess the benefit of guanethidine on the quantifiable objective measurement of algodystrophy and to determine its effect on the natural history of the disease.
Patients and methods From March to August 1991 all patients with
Colles' fracture were assessed at nine weeks after fracture for evidence of algodystrophy. Twenty patients fulfilled the criteria for diagnosis, namely an abnormal dolorimetery ratio, considerable finger swelling and stiffness, and the presence of vasomotor instability. The first 10 were treated by serial guanethidine blockade until clinical improvement. At this time reports that guanethidine blockade might be no better than transient inflation of a tourniquet prompted us to review our treatment policy (Casale et al3) and hence the next 10 patients were not offered guanethidine blockade. In every other aspect treatment of the two groups was identical. Fortuitously, this gave us an opportunity to investigate the response to guanethidine blockade.
After fracture the patients were treated in a plaster cast for five weeks, all fractures having been manipulated under intravenous regional analgesia.
ASSESSMENT METHODS

Subjective
After each guanethidine block the patients were asked to assess improvement in each of their symptoms using a visual analogue scale. 7 Objective Assessments of features of algodystrophy were made using techniques described in detail elsewhere,8 and reproducibility studies were performed in 20 control patients.
(1) Finger tenderness. Using a dolorimeter, a ratio of abnormal/normal hands was obtained. The 95% lower confidence limits of the dolorimetry ratio in normal subjects of this age is 0 90. The reproducibility of the method was 2-28%.
(2) Swelling. Circumference of the fingers was measured using an arthrocircameter.9 The normal range was -25 mm to +25 mm. The reproducibility of method was 7 19%.
(3) Finger stiffness. A total range of movement of the finger joints of each hand was obtained using a goniometer. The value for joint stiffness was found by subtracting the total for one hand from the other (normal range -630 to +63°; reproducibility was 1 47%).
(4) Vasomotor instability. This was assessed by a questionnaire.8 Each feature was scored as 0 (absent) or 1 (present) and the sum of these scores was used to give a semiquantitative assessment of vasomotor instability.
(5) Grip strength. This was measured using a Jamar dynamometer,'0 and the value expressed as a ratio of the normal hand (normal range 0-75-1-27). Field, Atkins Patients in each group were assessed at nine weeks, at which time the diagnosis was made. The mean time from fracture to the start of treatment was three months (range two to four months), the timing of treatment depending on clinical severity. In each patient treated there was a transient vasodilatory response indicating successful sympathetic interruption.
In the treated group, subjective assessments 1 0r
of the change in symptoms using visual analogue scales were made after each block.7 Patients were assessed objectively before and between 24 and 48 hours after each block. After treatment all patients were reviewed monthly for six months; guanethidine blockade was repeated if the patient had sufficient subjective symptoms up to a maximum of four blocks. Ten patients received two blocks, eight received three blocks, and six received four blocks. The significance of differences between means was assessed using Student's t test. This study was approved by the local ethical committee.
Results
There was no significant difference between the treated and untreated group in age, sex, Frykman1' and Lidstrom"2 fracture type (the former taking into account the ulnar styloid, the latter fracture displacement), number of manipulations, or adequacy of reduction. 4 3 Block number Figure 1 Improvements infinger tenderness measured by dolorimetry ratio before and after each guanethidine block (mean (SEM)). relieving the physical abnormalities of the disorder as opposed to altering the sympathetic outflow to the limb has been mainly subjective.'
The treated group achieved short term objective improvements in finger tenderness, finger stiffness, swelling, and grip strength and these correlated with the patients' subjective impression of improvement, suggesting that the methods used are indeed assessing the disability which the patients experience from the syndrome.
In contrast, the effect on the natural history is less clear. It has been reported that the symptoms of algodystrophy improve with time after Colles' fracture.'3 These results confirm this improvement but also show that guanethidine blockade administered under this regimen resulted in a significant improvement in pain only in the long term.
Four blocks have been recommended as the maximum before more permanent sympathetic blockade is considered.'4 As all the patients treated obtained symptomatic benefit with four or less blocks, it was difficult to justify giving more; however, further blocks may have given more improvement and it may be argued that all patients should have received the same number of blocks.
There are a number of flaws in this study. The patients were not randomised, though they were well matched and the numbers studied were small. The changes in objective features in the short term and the finding of a significant improvement in finger tenderness over the longer period, however, suggests that this approach may be useful for further investigations of the efficacy of guanethidine blockade in the treatment of algodystrophy.
